Other languages Kinnate Biopharma Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 02/04/2024 BST			5-day change	1st Jan Change
2.65 ^USD	-0.38%		0.00%	+11.81%

04-03	Kinnate Biopharma Inc. Announces Board Resignations	CI
04-03	Kinnate Biopharma Inc.(NasdaqGS:KNTE) dropped from NASDAQ Composite Index	CI

Kinnate Biopharma Inc. Announces Board Resignations	04-03
XOMA Corporation completed the acquisition of Kinnate Biopharma Inc..	04-02
Kinnate Biopharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Kinnate Biopharma Sells Cancer Treatment Assets to Pierre Fabre Laboratories	03-01
Sector Update: Health Care Stocks Advance Friday Afternoon	02-16
XOMA Agrees to Acquire Kinnate Biopharma	02-16
Kinnate Biopharma Plans to Further Reduce Workforce by 56%	01-17
Sector Update: Health Care Stocks Mixed Late Afternoon	11-15
Top Midday Gainers	11-15
Top Premarket Gainers	11-15
Kinnate Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Sector Update: Health Care Stocks Mixed Premarket Tuesday	19/09/23
Sector Update: Health Care	19/09/23
Kinnate Biopharma to Cut Workforce by 70% -- Shares Tumble After-Hours	18/09/23
Kinnate Biopharma Inc. Announces Workforce Restructuring	18/09/23
Kinnate Biopharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23
Kinnate Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Kinnate Biopharma Inc. acquired the remaining stake in Kinnjiu Biopharma Limited for $24 million.	10/05/23
Insider Buy: Kinnate Biopharma	10/05/23
Insider Buy: Kinnate Biopharma	08/05/23

No results for this search